Chrono Therapeutics

About:

Chrono Therapeutics was founded by Guy DiPierro to cause a paradigm shift in the way addictions and diseases are treated.

Website: http://chronothera.com

Twitter/X: chronothera

Top Investors: National Institutes of Health, Mayo Clinic, Cota Capital, Asahi Kasei, MedCity News

Description:

Chrono Therapeutics (CHRONO) is a pharmaceutical company founded in 2004 with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) that offers real-time behavioral support. Chrono’s executive leadership combines years of professional experience and personal passions for developing life-saving medical products. Steeped with years of experience in product development, science, R&D an understanding of the consumer smoking cessation market, FDA approval experience and bringing life-saving products to market, the team represents a wide-array of knowledge that combined can help address the serious epidemic of smoking.

Total Funding Amount:

$82.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hayward, California, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)chronothera.com

Founders:

Alan J. Levy, Guy DiPierro

Number of Employees:

11-50

Last Funding Date:

2016-09-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai